Caloric restriction doesn't extend lifespan—it delays immune aging
Caloric restriction is the most replicated longevity intervention. But what if its primary mechanism isn't metabolic—it's immunological?
The 2022 CALERIE trial—first controlled CR study in healthy humans—showed the most dramatic changes weren't in metabolism. They were in immune cell composition. CR subjects showed preserved naïve T-cell populations, reduced inflammatory monocytes, and maintained thymic output.
The thymus—our T-cell factory—involutes with age, driven by lipid accumulation in thymic epithelial cells. CR prevents this lipotoxicity, maintaining thymic function decades longer. The downstream effect: better immune surveillance catching senescent cells, pre-cancerous cells, and infections—cascading into every organ system.
Key evidence:
- Thymus removal in young mice abolishes ~60% of CR's lifespan benefit (Yang et al., Science 2023)
- CR mimetics (rapamycin, metformin) have strongest effects on immune function
- The immune system is the only organ that actively surveils and removes damaged cells body-wide
Testable prediction: Targeted thymic rejuvenation (FOXN1 upregulation, IL-7 therapy, or thymic epithelial cell transplantation) should replicate 60-70% of CR's healthspan benefits without dietary modification.
We don't need to starve ourselves. We need to keep our immune system young. Intervene Immune already showed proof of concept—growth hormone + DHEA + metformin reversing thymic involution and epigenetic age in the TRIIM trial.
Why is everyone counting calories when the answer might be in the thymus?